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A new wheat dimeric a-amylase inhibitor, designated WDAI-3, has been characterized. WDAI-3 is a 
homodimeric protein active against a-amylase from human saliva and from the insect Tenebrio molitor, but 
inactive against that from pig páncreas or against trypsin. Its N-terminal amino acid sequence is closer to those 
of the wheat dimeric inhibitors 0.19 and 0.53 (89 — 91% identical positions in 44 residues) than to that of the 
monomenc 0.28 inhibitor (69% identical positions). Iha-Bl-2, the gene encoding the new inhibitor, is located in 
the short arm of chromosome 3B, where it is part of an intrachromosomal gene duplication that also codes for 
the 0.53 inhibitor. 
Up to ten families of proteinaceous inhibitors of hetero-
logous hydrolytic enzymes (proteases and a-amylases) have 
been included in a recent review on the subject [1]. These 
inhibitors are currently attracting considerable attention be-
cause of their possible implication in defense mechanisms [1 — 
4]. Studies concerning their chemistry and genetic control, as 
well as their manipulation in plant breeding, are therefore 
relevant in this context. 
One of the protein families, which includes both trypsin 
inhibitors and the subunits of monomenc, dimeric and 
tetrameric inhibitors of heterologous a-amylases, has been 
extensively studied in several cereal species, especially in wheat 
and barley [1, 5,6], where they represent a substantial fraction 
of the grain protein. This group of inhibitors is encoded by a 
multigene family which is dispersed over several chromosomes 
[1, 7 — 14], and is homologous to the sulphur-rich domain of 
major cereal prolamins [15]. In wheat, some of the monomeric 
and dimeric a-amylase inhibitors have been characterized [1, 
5, 16] and, in particular, the complete amino acid sequences 
of two dimeric (0.53 and 0.19) and one monomeric (0.28) 
inhibitor have been determined [17 — 19]. Genes for inhibitors 
0.53 and 0.19 have been assigned to the short arms of 
chromosomes 3B and 3D, respectively, whereas the location 
of the gene for inhibitor 0.28 has been found in the short arm 
of chromosome 6D [11]. 
Further knowledge of the inhibitory properties of different 
components of this protein family and of the chromosomal 
distribution of their corresponding genes is warranted in con-
nection with an assessment of their possible plant protection 
role. We report here a new wheat dimeric inhibitor of 
heterologous a-amylases and the chromosomal location of the 
corresponding gene, which, together with the gene encoding 
inhibitor 0.53, represents a duplication in the short arm of 
chromosome 3B of hexaploid wheat (Triticum aestivum L.; 
genomes AABBDD). 
MATERIALS AND METHODS 
Isolation and characterization of the inhibitor 
A crude inhibitor preparation was obtained from Triticum 
turgidum (genomes AABB) cv. Senatore Capelli by 0.15 M 
NaCl extraction and (NH^SO* precipitation as previously 
described [12, 20]. This preparation was subjected to gel fil-
tration on Sephadex G-100 and fractions around 25 kDa 
which included the dimeric inhibitors, were pooled. The 
pooled fractions were chromatographed on a preparative 
high-performance liquid-chromatography (HPLC), reverse-
phase column (Vydac-C4, 22 mm x 250 mm, particle size 
10 um), using a two-step linear gradient 20 — 50% acetonitrile 
in 0.1 % trifluoroacetic acid (2 ml/min; linear 20 — 35% gradi-
ent in 140 min, linear 35 — 50% gradient in 100 min). 
HPLC gel filtration was carried out on a Spherogel TSK-
G300 column (21.5 mm x 300 mm). Purified proteins (50 ug) 
were eluted at 1 ml/min with 100 mM ammonium acétate, 
pH 6.8, with or without 0.1% SDS, as indicated in the text. 
A monomeric (0.28) and a dimeric (0.19) inhibitor, purified 
as previously described [11], were used for comparison. 
Protein sequencing was performed by standard methods, 
using an Applied Biosystems 470A gas-phase sequenator. 
Inhibition of different a-amylases was tested essentially 
according to Benfeld [21], with a 20 mM NaCl, 0.1 mM 
CaCl2, pH 5.4 buffer for Tenebrio molitor a-amylase, a 20 mM 
potassium phosphate, 67 mM NaCl, 0.1 mM CaCl2) pH 6.9, 
buffer for human saliva a-amylase, and the same buffer at 
pH 7.6 for pig páncreas a-amylase. 1 unit enzyme was used/ 
assay, defined as the amount of enzyme required to produce 
the reducing equivalents of 1 umol maltose in our experimen-
tal conditions. Trypsin inhibition was tested as in Boisen 
and Djurtoft [22]. Protein concentration was determined by 
standard methods [23,24]. Polyacrylamide gel electrophoresis 
in sodium dodecyl sulphate, SDS/PAGE [25], and two-
dimensional electrophoresis by combined electrofocusing and 
starch-gel electrophoresis were carried out as previously de-
scribed [26]. 
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Fig. \. (A) Ge! filtration on Sephadex G-100 of a 150 mM NaCl extract precipitated with 50% saturated (NH4)2S04 (crude inhibitor 
preparation) from tetraphid wheat. The fraction indicated by a horizontal bar was used for further purification steps. Bovine serum albumin 
(67 kDa), ovalbumin (45 kDa), chymotrypsinogen (25 kDa) and cytochrome c (12.3 kDa) were the standards used to calíbrate the column. 
Inhibitory activity against salivary a-amylase was assayed in appropriate aliquots from cvery second tube. (B, C) Two-dimensional 
electrophoretic maps (electrofocusing, IEFxstarch-gel electrophoresis, SGE) of the crude inhibitor preparation (B) and of the 25-kDa gel-
fütration fraction (C) indicated in (A). Arrows point to the positions of WDAI-3, and of the dimeric a-amylase inhibitor 0.53 
Fig. 2. (A) HPLCfractionation on Vydac-CA column of the 25-kDa gel-fdtration fraction shown in Fig. I A. Thepeak corresponding to WDAI-
3 is indicated. (B) SDS-PAGE of samples from tetraphid wheat endosperm. (1) Crude inhibitor preparation; (2) 25-kDa gel-filtration fraction 
from Fig. 1 A; (3) purified WDAI-3; (4) purified 0.53 a-amylase dimeric inhibitor. The molecular masses of reference proteins in kDa appear 
on the right side of the figure 
Genetic analysis 
Compensated nulli-tetrasomic and ditelosomic Unes of T. 
aestivum cv. Chinese Spring (gift of E. R. Sears, Columbia, 
MO, USA) were used to lócate the structural gene for the 
inhibitor. The 70% ethanol extracts of these genetic stocks 
were fractionated by two-dimensional electrophoresis as de-
scribed above. The precise location of spots corresponding to 
purified proteins was determined by co-electrophoresis with 
the euploid extract and with that of the appropriate aneuploid 
line. 
RESULTS 
Isolation and characterization of inhibitor WDAI-3 
A crude inhibitor preparation was obtained from tetra-
ploid wheat endosperm and then fractionated by gel filtration 
on Sephadex G-100. The fraction with apparent molecular 
mass around 25 kDa, which included the dimeric inhibitors 
and was highly active against human salivary a-amylase 
(Fig. 1 A), was shown to consist of two main components 
and several minor ones by two-dimensional electrophoresis 
(Fig. 1B, C). One of the two main components was identified 
as the previously characterized dimeric inhibitor 0.53 [11,19] 
by co-electrophoresis with an authentic sample (not shown). 
The second main component was obtained by preparative 
HPLC of the 25-kDa gel filtration fraction (Fig. 2 A). Hom-
ogeneity of this component (WDAI-3) was checked by two-
dimensional electrophoresis (not shown) and by SDS/PAGE, 
where it appeared with a molecular mass of 12.7 kDa 
(Fig. 2B). WDAI-3 was shown to form dimers by gel filtration 
on a Spherogel TSK-G300 HPLC column. Under non-dis,-
sociating conditions, it eluted as the previously reported 
dimeric inhibitor 0.19 and at a lower elution volume than the 
monomeric inhibitor 0.28, whereas under dissociating con-
ditions, the same elution volume was obtained for the three 
inhibitors (Fig. 3). 
The first 44 residues of its N-terminal amino acid sequence 
were determined and aligned with those of previously known 
monomeric and dimeric inhibitors (Fig. 4). Although a high 
similarity of WDAI-3 to both types of inhibitors was evident, 
the sequence of the new inhibitor was closer to those of the 
dimeric ones (Fig. 4). 
The new inhibitor was about tenfold more active than the 
monomeric 0.28 inhibitor against human salivary a-amylase 
(Fig. 5 A), and about one-tenth as active as 0.28 against insect 
a-amylase (Fig. 5B). None of the tested inhibitors was active 
against the a-amylase of pig páncreas (up to 2 ug inhibitor/ 
assay) or against trypsin (up to 10 ug/assay). 
Chromosomal location ofthe gene encoding WDAI-3 
The chromosomal location of the gene encoding WDAI-
3, designated Iha-Bl-2, was investigated by analysis of the 
compensated nulli-tetrasomic and the ditelosomic series of 
lines of hexaploid wheat cv. Chínese Spring. Two-dimensional 
electrophoresis of the 70% ethanol extracts was chosen as 
the method of analysis because it had been previously shown 
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Fig. 3. HPLC gel filtration on a Spherogel TSK-G300 SWG column 
of the indicated purified inhibitors. The elution buffer was 100 mM 
ammonium acétate, pH 6.8, or the same buffer with 0.1 % SDS. Arrow 
heads point to the elution volumes of chymotrypsinogen (25 kDa) 
and cytochrome c (12.3 kDA) 
that the inhibitors were readily extractable with this solvent, 
and that the corresponding two-dimensional patterns were 
simpler and with less overlapping than those obtained for the 
H 2 0 or 0.15 M NaCl extracts [7, 9, 11]. The presence of 
WDAI-3 in hexaploid wheat was demonstrated by co-
electrophoresis of the purified inhibitor with the hexaploid 
wheat extract (not shown). The spot corresponding to WDAI-
3 was present in all lines tested except those lacking either 
chromosome 3B or just its short arm (Fig. 6). The spot corre-
sponding to inhibitor 0.53 was also missing in the same genetic 
stocks, in agreement with a previous report [11]. 
DISCUSSION 
The new inhibitor, WDAI-3, is one of the major 
components of the crude inhibitor preparation (Fig. 1) and 
of the low-molecular-mass fraction from the 70% ethanol 
extract of wheat (Fig. 6). WDAI-3 is extracted as a dimer 
(Fig. 1 A) and is able to self-associate in vitro (Fig. 3). Its 
dimeric nature is further corroborated by its amino acid se-
quence, which is closer to previously described wheat dimeric 
inhibitors than to the monomeric one [17—19]. The fact that, 
as is the case for the other dimeric inhibitors [5,16], WDAI-3 
is significantly more active than the monomeric 0.28 inhibitor 
against salivary a-amylase, and markedly less active than 0.28 
towards the enzyme from the insect T. molitor, suggests that 
there are not significant differences in specificity within the 
dimeric class of inhibitors, which are more active against 
salivary a-amylase than against the insect a-amylase, whereas 
the opposite is true both for the monomeric and the tetrameric 
inhibitors [1, 5, 12, 27]. It will be of interest if other possible 
minor components of the dimeric class have the same or 
different specificity as those already reported. 
The location of gene Iha-Bl-2 on the same chromosome 
arm (3BS) as the gene encoding the 0.53 dimeric inhibitor 
[11], which is clearly homologous to WDAI-3 (91% identical 
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Fig. 4. Aligment ofthe N-terminal sequence of WDAl-3 with those ofthe wheat dimeric inhibitors 0.19 and 0.53 [18,19] and the wheat monomeric 
inhibitor 0.28 [17]. Percentages of identical residues for all binary comparisons are listed at the right ofthe figure 
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Fig. 5. Inhibitory activities against the a-amylases from human saliva (A) and from the insect Tenebrio molitor (B) of the indicated wheat 
inhibitors. Inhibition tests were carried out using 1 unit a-amylase (see Materials and Methods). Vertical bars indícate standard deviations 
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Fig. 6. Two-dimensional electrophoretic protein maps (electrofocusing, IEF, and starch-gel eleclrophoresis, SGE) of 70% ethanol extracts from 
individual endosperms. (A) T. turgidum cv. Senatore Capelli. (B) T. eastivum cv. Chinese Spring. (C) Ditelosomic 3BL. (D) Ditelosomic 3BL 
plus 10 ug purified WDA1-3. Arrows point to the positions of WDAI-3, inhibitor 0.19 and inhibitor 0.53 
residues in 44 positions), indicates that an intrachromosomal 
gene duplication has occurred in chromosome 3B. On the 
basis of the N-terminal 44 amino acid residues, dimeric inhibi-
tor 0.19, whose gene is on the short arm of chromosome 3D 
[11], seems to be closer to inhibitor 0.53 than WDAI-3 (95% 
vs. 9 1 % identical positions). This suggests that, excluding 
some special type of sequence homogeneization, the dupli-
cation must have occurred before the evolutionary branching 
out of Triticum tauschii, donor of the D genome to cultivated 
wheat, and the unknown donor of the B genome. 
The considerable divergence that has occurred within this 
protein family, which is reflected in the diversification of 
amino acid sequences and of other structural features, in the 
dispersión of the corresponding genes by duplication and 
translocation [1, 5, 13], and in the range of inhibitory 
specifities that it represents, is consistent with a protective 
role against predators. However, the evidence presented here 
confirms previous indications [1, 5, 8, 28] of the low in-
traspecific variability of individual members of the family (i.e. 
WDAI-3 has been conserved across the hexaploidization step) 
and of the not-recent origin of the observed divergence (i.e. 
ancient origin of the duplication). This suggests that the puta-
tive defense system would be in place in order to meet long-
standing challenges rather than rapidly evolving in response 
to emerging ones. 
No other function has been postulated for this protein 
family, except for a possible reserve role [1]. Presumably, this 
less specific role should have allowed a greater intraspecific 
variability than that observed at the different loci [1]. 
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